Glutamate for Metabolic Intervention in Coronary Surgery II
Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II
Sponsor: Region Örebro County
Listed as NCT02592824, this PHASE3 trial focuses on Coronary Artery Bypass Surgery and Heart Failure and remains completed. Sponsored by Region Örebro County, it has been updated 12 times since 2015, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
12 versions recorded-
Mar 2025 — Present [monthly]
Completed PHASE3
-
Feb 2025 — Mar 2025 [monthly]
Completed PHASE3
-
Sep 2024 — Feb 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2024 — Jul 2024 [monthly]
Completed PHASE3
▶ Show 7 earlier versions
-
Jan 2021 — Jan 2024 [monthly]
Completed PHASE3
-
Dec 2020 — Jan 2021 [monthly]
Completed PHASE3
Status: Recruiting → Completed
-
Oct 2020 — Dec 2020 [monthly]
Recruiting PHASE3
-
Apr 2020 — Oct 2020 [monthly]
Recruiting PHASE3
-
Jun 2019 — Apr 2020 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Region Örebro County
- Sahlgrenska University Hospital
- University Hospital, Linkoeping
- University Hospital, Umeå
For direct contact, visit the study record on ClinicalTrials.gov .